about
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensBidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model.Basic obstetric pharmacology.Transplacental passage of vancomycin.Ex Vivo Dual Perfusion of the Human Placenta: Disease Simulation, Therapeutic Pharmacokinetics and Analysis of Off-Target Effects.An advanced human in vitro co-culture model for translocation studies across the placental barrier.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 August 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transplacental transfer of vancomycin and telavancin
@en
Transplacental transfer of vancomycin and telavancin.
@nl
type
label
Transplacental transfer of vancomycin and telavancin
@en
Transplacental transfer of vancomycin and telavancin.
@nl
prefLabel
Transplacental transfer of vancomycin and telavancin
@en
Transplacental transfer of vancomycin and telavancin.
@nl
P2093
P2860
P1476
Transplacental transfer of vancomycin and telavancin
@en
P2093
Gary D V Hankins
Mahmoud S Ahmed
Svetlana Patrikeeva
Tatiana Nanovskaya
Valentina Fokina
P2860
P304
P356
10.1016/J.AJOG.2012.06.064
P407
P577
2012-08-04T00:00:00Z